AAstraZeneca Read More A merged AstraZeneca and BMS could lead Lilly on revenue until about 2030August 4, 2026 In a potential marriage that analysts said faces long odds, AstraZeneca and Bristol Myers Squibb have held talks…
AAstraZeneca Read More AstraZeneca Datroway Wins EU Approval, 5-Month OS GainAugust 2, 2026 See more from StockTitan in Google Search…
AAstraZeneca Read More AstraZeneca wins EU approval for Datroway in TNBC | AZN SEC FilingAugust 1, 2026 FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant…
AAstraZeneca Read More AstraZeneca’s Datroway and Enhertu candidates receive EU approvalJune 29, 2026 Drugmaker AstraZeneca said on Monday that its breast cancer therapy Datroway has been recommended for approval in the…
AAstraZeneca Read More AZN, Daiichi’s Datroway Wins FDA Nod for Expanded Use in Breast CancerMay 25, 2026 AstraZeneca AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has approved their blockbuster antibody-drug conjugate (ADC),…
AAstraZeneca Read More AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBCMay 25, 2026 AstraZeneca and Daiichi Sankyo have secured approval from the US Food and Drug Administration (FDA) for Datroway (datopotamab…